Hidetoshi Takedatsu

7PUBLICATIONS
28CO-AUTHORS
Infant and child healthPredictive and prognostic markersAllergyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2025
Long-Term Response Durability of Infliximab for Pediatric Inflammatory Bowel Disease in Japan: A Single Center Experience.

Naoya Tsumura, Ken Kato, Ryosuke Yasuda

|May 19, 2025
Efficacy of Filgotinib in Moderate to Severe Ulcerative Colitis: A Prospective Study Using Partial Mayo Score, Ulcerative Colitis Endoscopic Index of Severity, and Geboes Histopathology Score.

Yoshiyuki Shirouzu, Hideki Ishibashi, Masayoshi Kage

|Oct 14, 2022
Utility of Diagnostic Colonoscopy in Pediatric Intestinal Disease.

Masaru Morita, Hidetoshi Takedatsu, Shinichiro Yoshioka

|Jan 14, 2022
Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis.

So Imakiire, Hidetoshi Takedatsu, Keiichi Mitsuyama

|Feb 17, 2021
Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease.

Toshihiro Araki, Keiichi Mitsuyama, Hiroshi Yamasaki

|Mar 08, 2018
Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Hidetoshi Takedatsu, Keiichi Mitsuyama, Shuhei Fukunaga

Pageof 2

Frequent Collaborators

2 joint publications

Keiichi Mitsuyama

2 joint publications

Hideki Ishibashi

2 joint publications

Shinichiro Yoshioka

2 joint publications

Tatsuki Mizuochi